[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

8 clusters · 21 sources · 61 days · First seen · Last updated

Global health risks and complications of RSV

Overview

Respiratory Syncytial Virus (RSV) remains a major global health threat, causing approximately 2.2 million infant hospitalizations and 66,300 deaths in young children annually. In Vietnam, experts estimate 9 out of 10 children contract the virus within their first two years. Dr. Truong Huu Khanh has warned that severe infections in the first year can lead to long-term complications like asthma and reduced lung function. Ha Tinh General Hospital has reported surges in pediatric cases, noting that many patients arrive in severe condition after families attempt home treatment for symptoms mistaken for common colds.

In Poland, medical professionals observed that nearly 95% of hospitalized children had no prior risk factors for severe disease. Transmission often occurs through close contact with family members. Beyond infants, RSV poses significant risks to the elderly and those with cardiovascular conditions; inflammation and oxygen deficiency from RSV can trigger acute cardiac events. A systematic review led by Duke-NUS Medical School found that while lung dysfunction is common after influenza, heart-related events are most consistently observed following RSV infections.

Recent data highlights the impact on older populations. The ROSA study in Portugal found a 20% hospital mortality rate for RSV patients, exceeding the 13% seen in influenza cases. However, a large-scale U.S. study of Medicare beneficiaries indicates that RSV vaccines can reduce the risk of hospitalization by 81.8% and death by 85% in adults aged 65 and older. In Belgium, experts emphasize that while influenza and COVID-19 are standard vaccination focuses, RSV remains an overlooked threat for high-risk adults with comorbidities.

Entities

JAMA Network Open · Ministry of Health · Ho Chi Minh City Infectious Diseases Association · Nicolas Dauby · Respiratory Syncytial Virus

Timeline

  1. [HEALTH] 2 sources
    Respiratory virus risks and aging physiological changes

    Medical experts highlight the risks of RSV in older adults and explain how aging affects thermoregulation and metabolism.

  2. [HEALTH] 2 sources
    RSV vaccines reduce elderly hospitalization and death risk by over 80%

    A major study of nearly 15 million Medicare beneficiaries shows RSV vaccines reduce hospitalization risk by 82% and death risk by 85% among adults aged 65 and older in the United States.

  3. [HEALTH] 2 sources
    RSV impact on elderly highlighted by ROSA study

    The ROSA study in Portugal reveals that RSV causes higher mortality and hospitalization costs in adults than influenza, prompting calls for expanded state-funded protection for the elderly.

  4. [HEALTH] 2 sources
    Ha Tinh hospital reports surge in pediatric RSV cases

    Ha Tinh General Hospital reports a surge in pediatric RSV cases, with over 10 children admitted daily. Doctors warn of risks from delayed treatment and emphasize monitoring for severe respiratory symptoms.

  5. [HEALTH] 2 sources
    Respiratory viruses linked to long-term lung and heart complications

    A major review shows influenza and RSV can cause long-term lung and heart issues, highlighting the importance of seasonal vaccinations for COVID-19, flu, and RSV.

  6. [HEALTH] 3 sources
    Respiratory infections pose severe risks to children and heart patients

    Medical experts warn that respiratory infections like RSV and influenza pose severe risks, including dangerous co-infections in children and increased cardiovascular complications in heart patients.

  7. [HEALTH] 5 sources
    RSV poses high risks to infants and seniors

    Experts warn that RSV is a major cause of infant hospitalization and poses high risks to seniors, emphasizing the need for prevention to reduce the burden on healthcare systems.

  8. [HEALTH] 3 sources
    Respiratory Syncytial Virus causes 2.2 million infant hospitalizations annually

    Respiratory Syncytial Virus (RSV) causes 2.2 million infant hospitalizations annually worldwide, potentially leading to long-term respiratory issues like asthma and reduced lung function.

Sources

afamily.vn · agriniosite.gr · baochinhphu.vn · baohatinh.vn · biznesalert.pl · blackwpc.org · doctissimo.fr · iatropedia.gr · jornal.usp.br · kenh14.vn · medicaldaily.com · musees.ulb.be · naukawpolsce.pap.pl · observador.pt · radioswinoujscie.pl · soha.vn · sukcesjestkobieta.pl · tienphong.vn · tuoitre.vn · vtv.vn · zdrowie.co.pl

This summary has been updated 5 times: see revision history